Peregrine Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $5.52M | Sell |
|
|||||
|
2020
Q3 | $5.43M | Sell |
|
|||||
|
2020
Q2 | $7.51M | Sell |
|
|||||
|
2020
Q1 | $4.65M | Buy |
|
|||||
|
2019
Q4 | $12.2M | Sell |
|
|||||
|
2019
Q3 | $10.7M | Buy |
|
|||||
|
2019
Q2 | $9.3M | Sell |
|
|||||
|
2019
Q1 | $9.46M | Sell |
|
|||||
|
2018
Q4 | $8.75M | Sell |
|
|||||
|
2018
Q3 | $14.6M | Buy |
|
|||||
|
2018
Q2 | $17.2M | Buy |
|
|||||
|
2018
Q1 | $14.2M | Sell |
|
|||||
|
2017
Q4 | $16.6M | Buy |
|
|||||
|
2017
Q3 | $14.4M | Sell |
|
|||||
|
2017
Q2 | $14.3M | Sell |
|
|||||
|
2017
Q1 | $19.2M | Sell |
|
|||||
|
2016
Q4 | $14M | Buy |
|
|||||
|
2016
Q3 | $14.1M | Buy |
|